HK1075199A1 - Process for the preparation of crystalline nano-particle dispersions - Google Patents
Process for the preparation of crystalline nano-particle dispersionsInfo
- Publication number
- HK1075199A1 HK1075199A1 HK05107482.5A HK05107482A HK1075199A1 HK 1075199 A1 HK1075199 A1 HK 1075199A1 HK 05107482 A HK05107482 A HK 05107482A HK 1075199 A1 HK1075199 A1 HK 1075199A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- dispersion
- water
- particle dispersions
- insoluble substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Colloid Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Medicinal Preparation (AREA)
- Pigments, Carbon Blacks, Or Wood Stains (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Mixers With Rotating Receptacles And Mixers With Vibration Mechanisms (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
- Glass Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0216700.5A GB0216700D0 (en) | 2002-07-18 | 2002-07-18 | Process |
PCT/GB2003/003044 WO2004009057A1 (fr) | 2002-07-18 | 2003-07-14 | Procede de preparation de dispersions de nanoparticules cristallines |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1075199A1 true HK1075199A1 (en) | 2005-12-09 |
Family
ID=9940704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05107482.5A HK1075199A1 (en) | 2002-07-18 | 2005-08-25 | Process for the preparation of crystalline nano-particle dispersions |
Country Status (18)
Country | Link |
---|---|
US (1) | US7780989B2 (fr) |
EP (1) | EP1524964B1 (fr) |
JP (1) | JP2006504511A (fr) |
KR (1) | KR101061309B1 (fr) |
CN (1) | CN100594885C (fr) |
AT (1) | ATE489939T1 (fr) |
BR (1) | BR0312631A (fr) |
CA (1) | CA2492709C (fr) |
DE (1) | DE60335189D1 (fr) |
ES (1) | ES2355137T3 (fr) |
GB (1) | GB0216700D0 (fr) |
HK (1) | HK1075199A1 (fr) |
IL (1) | IL165930A0 (fr) |
MX (1) | MXPA05000595A (fr) |
NO (1) | NO20050860L (fr) |
NZ (1) | NZ537654A (fr) |
WO (1) | WO2004009057A1 (fr) |
ZA (1) | ZA200410343B (fr) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0211705A (pt) * | 2001-08-06 | 2004-09-28 | Astrazeneca Ab | Processo para a preparação de uma dispersão estável de partìculas sólidas em um meio aquoso, dispersão estável aquosa, partìcula sólida, composição farmacêutica, método para a inibição do amadurecimento de ostwald em uma dispersão de partìculas sólidas substancialmente insolúveis em água em um meio aquoso, e, uso de um inibidor |
GB0230087D0 (en) * | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
GB0230088D0 (en) * | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
GB0302671D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302673D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302672D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
US20050008691A1 (en) * | 2003-05-14 | 2005-01-13 | Arturo Siles Ortega | Bicalutamide compositions |
GB0314057D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
US20060135523A1 (en) * | 2003-06-18 | 2006-06-22 | Astrazeneca Ab | 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator |
GB0314261D0 (en) * | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
US7326706B2 (en) * | 2003-08-15 | 2008-02-05 | Bristol-Myers Squibb Company | Pyrazine modulators of cannabinoid receptors |
FR2861992B1 (fr) * | 2003-11-10 | 2007-07-20 | Sanofi Synthelabo | Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide. |
IL160858A (en) * | 2004-03-14 | 2015-09-24 | Adama Makhteshim Ltd | Nano-pesticide pesticide preparation and process for preparation |
WO2005123721A2 (fr) * | 2004-06-18 | 2005-12-29 | Ranbaxy Laboratories Limited | Formes amorphes et polymorphes de candesartan cilexetil |
NZ552392A (en) * | 2004-07-14 | 2010-02-26 | Sumitomo Chemical Co | Method of crystallizing bicalutamide |
US20060159767A1 (en) * | 2004-12-22 | 2006-07-20 | Elan Pharma International Limited | Nanoparticulate bicalutamide formulations |
BRPI0606434A2 (pt) * | 2005-01-06 | 2009-06-30 | Elan Pharma Int Ltd | formulações de candesartana nanoparticulada |
WO2006113309A1 (fr) * | 2005-04-15 | 2006-10-26 | Dr. Reddy's Laboratories Ltd. | Particules de lacidipine |
JP2007038117A (ja) * | 2005-08-02 | 2007-02-15 | Fujifilm Holdings Corp | 粒子製造方法 |
US20080305257A1 (en) * | 2005-12-13 | 2008-12-11 | Commissariat A Lenergie Atomique | Device and Method for the Production of Stabilised Suspensions of Nanometric or Submicrometric Particles |
JPWO2007072869A1 (ja) * | 2005-12-21 | 2009-06-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 1,2−ジヒドロピリジン化合物の非晶質体 |
WO2007103711A2 (fr) * | 2006-03-01 | 2007-09-13 | Dr. Reddy's Laboratories Ltd. | Formes polymorphes du rimonabant |
JP2010502698A (ja) * | 2006-09-05 | 2010-01-28 | アストラゼネカ アクチボラグ | カンデサルタンシレキセチルを含む医薬組成物 |
US20080217583A1 (en) * | 2006-10-20 | 2008-09-11 | James Hayes | Aerosol formulations comprising semiconductor nanocrystal compositions and methods of making the same |
JP5004333B2 (ja) * | 2006-12-08 | 2012-08-22 | 日機装株式会社 | ナノオーダ粒子製造装置 |
JP2010517759A (ja) * | 2007-02-09 | 2010-05-27 | アストラゼネカ・アクチエボラーグ | 水性媒体中における固体非晶質サブミクロン粒子の安定な分散体を製造する方法 |
FR2913018A1 (fr) * | 2007-02-23 | 2008-08-29 | Sanofi Aventis Sa | Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs |
JP5428058B2 (ja) * | 2007-12-28 | 2014-02-26 | ライオン株式会社 | 微粒化エラグ酸化合物の製造方法 |
KR20100052262A (ko) * | 2008-11-10 | 2010-05-19 | (주)아모레퍼시픽 | 난용성 약물의 나노입자를 포함하는 분말의 제조방법, 그에의해 제조된 분말 및 이를 포함하는 약학적 조성물 |
HUP0900384A2 (en) * | 2009-06-19 | 2011-01-28 | Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag | Nanoparticulate olmesartan medoxomil compositions |
EP2442794A1 (fr) * | 2009-06-19 | 2012-04-25 | Nanoform Hungary Ltd. | Compositions nanoparticulaires de telmisartan et procédé de préparation de celles-ci |
HUP0900376A2 (en) * | 2009-06-19 | 2011-01-28 | Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag | Nanoparticulate candesartan cilexetil composition |
RU2411133C1 (ru) * | 2009-08-07 | 2011-02-10 | Общество С Ограниченной Ответственностью "Новые Энергетические Технологии" | Вещество метки подлинности банкнот, ценных бумаг и документов и способ его приготовления |
GB0918431D0 (en) | 2009-10-21 | 2009-12-09 | Prosonix Ltd | Process for improving crystallinity |
US8920682B2 (en) * | 2010-03-19 | 2014-12-30 | Eastern Michigan University | Nanoparticle dispersions with ionic liquid-based stabilizers |
EP2587940B1 (fr) * | 2010-06-30 | 2014-08-06 | Unilever N.V. | Particules comprenant un polymère hydrophobe et un composé phénolique hydrophobe |
CN102048702B (zh) * | 2010-12-03 | 2012-05-23 | 山东大学 | 一种联苯双酯纳米结晶制剂及其制备方法 |
JP2014511867A (ja) * | 2011-04-18 | 2014-05-19 | 合肥貝霓医薬科技有限公司 | ジヒドロピリジン系カルシウムチャネルブロッカーの精製、及びそのナノ粒子の調製方法 |
CN102746215A (zh) * | 2011-04-18 | 2012-10-24 | 张兆勇 | 一种制备高纯度盐酸贝尼地平的方法 |
WO2013041944A1 (fr) | 2011-09-19 | 2013-03-28 | Ranbaxy Laboratories Limited | Procédé pour la préparation de candésartan cilexétil micronisé |
JP2014532655A (ja) * | 2011-10-31 | 2014-12-08 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | ナノ懸濁過程 |
CN102846554B (zh) * | 2012-09-28 | 2014-11-26 | 山东大学 | 一种h2纳米结晶制剂及其制备方法 |
KR102045732B1 (ko) * | 2012-12-28 | 2019-11-18 | 엘지디스플레이 주식회사 | 온도감응형 계면활성제를 이용한 수용성 나노입자의 제조방법 |
CN103145594B (zh) * | 2013-03-26 | 2014-12-17 | 四川农业大学 | 一种制备氟苯尼考微晶体的方法 |
CN106068319A (zh) * | 2014-03-10 | 2016-11-02 | 国立大学法人东京大学 | 水分散性非晶质粒子及其制备方法 |
CN107001810A (zh) * | 2014-12-15 | 2017-08-01 | M技术株式会社 | 有机物微粒的制造方法及有机物微粒的改性方法 |
CN107541209B (zh) * | 2016-06-28 | 2020-09-01 | 苏州大学 | 一种将油相纳米粒子转移至水相的方法 |
CN109020807B (zh) * | 2017-06-09 | 2022-06-24 | 鲁南制药集团股份有限公司 | 一种肉豆蔻酸钠晶型及其制备方法 |
CN107595772B (zh) * | 2017-09-26 | 2020-09-18 | 山东省药学科学院 | 一种他克莫司纳米混悬滴眼液的制备方法 |
CN108383887A (zh) * | 2018-03-14 | 2018-08-10 | 广东润华药业有限公司 | 一种替米考星纳米结晶的制备方法 |
CN109260159B (zh) * | 2018-11-29 | 2021-07-23 | 沈阳药科大学 | 一种含有艾地苯醌的药物组合物及其制备方法 |
CA3230398A1 (fr) * | 2021-08-31 | 2023-03-09 | Natsar Pharmaceuticals, Inc. | Formulations intraveineuses de rk-33 |
WO2024153857A1 (fr) | 2023-01-18 | 2024-07-25 | Nanoform Finland Oyj | Procédé de cristallisation d'ingrédients pharmaceutiques actifs |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4348385A (en) * | 1980-11-17 | 1982-09-07 | Mobay Chemical Corporation | Flowable pesticides |
DE3119383A1 (de) * | 1981-05-15 | 1982-12-02 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten |
JPS5851934A (ja) * | 1981-09-21 | 1983-03-26 | Kingo Yoshida | 超音波によるアモルフアス物質製造法 |
US4610868A (en) * | 1984-03-20 | 1986-09-09 | The Liposome Company, Inc. | Lipid matrix carriers for use in drug delivery systems |
US4826689A (en) | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
CA1282405C (fr) * | 1984-05-21 | 1991-04-02 | Michael R. Violante | Methode pour produire des particules dimensionnellement uniformes a partir des composes organiques insolubles dans l'eau |
FR2608988B1 (fr) | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules |
SE8700213L (sv) | 1987-01-21 | 1988-07-22 | Nobel Kemi Ab | Sett att framstella kristallina substanser |
JP3003148B2 (ja) | 1989-01-05 | 2000-01-24 | 藤沢薬品工業株式会社 | チアゾール化合物、その製造法およびそれを含有する医薬組成物 |
JPH03188438A (ja) | 1989-12-18 | 1991-08-16 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
ES2078447T3 (es) | 1990-06-15 | 1995-12-16 | Merck & Co Inc | Un procedimiento de cristalizacion para mejorar la estructura y el tamaño de los cristales. |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
MX9201782A (es) | 1991-04-19 | 1992-10-01 | Sandoz Ag | Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene. |
US5932245A (en) | 1991-12-05 | 1999-08-03 | Alfatec Pharma Gmbh | Gelatin or collagen hydrolysate containing drug formulation that provides for immediate release of nanoparticle drug compounds |
FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
US5674514A (en) | 1992-09-21 | 1997-10-07 | Ciba-Geigy Corporation | Storage stable pesticidal aqueous emulsions |
US5468604A (en) * | 1992-11-18 | 1995-11-21 | Eastman Kodak Company | Photographic dispersion |
US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
DE19609538A1 (de) * | 1996-03-11 | 1997-09-18 | Basf Ag | Feinverteilte Carotinoid- und Retinoidsuspensionen und Verfahren zu ihrer Herstellung |
GB2276567B (en) | 1993-04-03 | 1996-11-27 | Atomic Energy Authority Uk | Processing vessel |
GB9319129D0 (en) | 1993-09-15 | 1993-11-03 | Dowelanco Ltd | Storage and dilution of stable aqueous dispersions |
SE9303281D0 (sv) | 1993-10-07 | 1993-10-07 | Astra Ab | New formulation |
SE9403846D0 (sv) | 1994-11-09 | 1994-11-09 | Univ Ohio State Res Found | Small particle formation |
DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
US5665331A (en) * | 1995-01-10 | 1997-09-09 | Nanosystems L.L.C. | Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers |
US5534270A (en) | 1995-02-09 | 1996-07-09 | Nanosystems Llc | Method of preparing stable drug nanoparticles |
SE9501384D0 (sv) | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
TW493991B (en) | 1995-05-08 | 2002-07-11 | Novartis Ag | Pharmaceutical composition for oral administration of active agent having low water solubility and process for preparation of the same |
AU6546496A (en) | 1995-07-26 | 1997-02-26 | Nanosystems L.L.C. | Methacrylate backbone surfactants in nanoparticulate formulations |
TW487582B (en) * | 1995-08-11 | 2002-05-21 | Nissan Chemical Ind Ltd | Method for converting sparingly water-soluble medical substance to amorphous state |
US5834025A (en) | 1995-09-29 | 1998-11-10 | Nanosystems L.L.C. | Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
WO1997013503A1 (fr) | 1995-10-13 | 1997-04-17 | The Penn State Research Foundation | Synthese de nanoparticules medicamenteuses par sechage par pulverisation |
PT951280E (pt) | 1996-10-03 | 2004-05-31 | Hermes Biosciences Inc | Microparticulas hidrofilicas e metodos para a sua preparacao |
GB9624615D0 (en) | 1996-11-26 | 1997-01-15 | Zeneca Ltd | Chrystallisation process |
IL133672A0 (en) | 1997-06-27 | 2001-04-30 | Vivorx Pharmaceuticals Inc | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
FR2766368B1 (fr) | 1997-07-24 | 2000-03-31 | Univ Claude Bernard Lyon | Procede de preparation de nanocapsules de type vesiculaire, utilisables notamment comme vecteurs colloidaux de principes actifs pharmaceutiques ou autres |
GB9810859D0 (en) | 1998-05-20 | 1998-07-22 | Zeneca Ltd | Crystallisation process |
DE19856432A1 (de) | 1998-12-08 | 2000-06-15 | Basf Ag | Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen |
GB9828721D0 (en) | 1998-12-24 | 1999-02-17 | Glaxo Group Ltd | Novel apparatus and process |
CN1182903C (zh) * | 1999-01-29 | 2005-01-05 | 布里斯托尔-迈尔斯斯奎布公司 | 声波冲击喷射结晶设备和工艺 |
FR2789079B3 (fr) | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
CA2684454A1 (fr) | 1999-05-21 | 2000-11-18 | American Bioscience, Llc. | Agents a stabilisation proteinique actifs pharmacologiquement; procedes de fabrication et methodes d'utilisation |
GB9925934D0 (en) * | 1999-11-03 | 1999-12-29 | Glaxo Group Ltd | Novel apparatus and process |
JP2004500401A (ja) | 2000-03-23 | 2004-01-08 | ソルベイ・フアーマシユーチカルズ・ベー・ブイ | Cb1−拮抗活性を有する4,5−ジヒドロ−1h−ピラゾール誘導体 |
WO2001092293A2 (fr) | 2000-05-31 | 2001-12-06 | Universiteit Leiden | Nano-cristallogenese, procede de fabrication de cristaux, compositions comprenant lesdits cristaux et leurs utilisations |
GB0016002D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
GB0016040D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
WO2002055059A2 (fr) * | 2000-12-22 | 2002-07-18 | Baxter Int | Preparation de suspensions de particules submicroniques |
US7037528B2 (en) * | 2000-12-22 | 2006-05-02 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
BR0211705A (pt) * | 2001-08-06 | 2004-09-28 | Astrazeneca Ab | Processo para a preparação de uma dispersão estável de partìculas sólidas em um meio aquoso, dispersão estável aquosa, partìcula sólida, composição farmacêutica, método para a inibição do amadurecimento de ostwald em uma dispersão de partìculas sólidas substancialmente insolúveis em água em um meio aquoso, e, uso de um inibidor |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
GB0125604D0 (en) | 2001-10-25 | 2001-12-19 | Glaxo Group Ltd | Novel process |
SE0104330D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
SE0104332D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
GB0302672D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302671D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302673D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
-
2002
- 2002-07-18 GB GBGB0216700.5A patent/GB0216700D0/en not_active Ceased
-
2003
- 2003-07-14 WO PCT/GB2003/003044 patent/WO2004009057A1/fr active IP Right Grant
- 2003-07-14 MX MXPA05000595A patent/MXPA05000595A/es active IP Right Grant
- 2003-07-14 US US10/521,617 patent/US7780989B2/en not_active Expired - Fee Related
- 2003-07-14 ES ES03738346T patent/ES2355137T3/es not_active Expired - Lifetime
- 2003-07-14 JP JP2004522299A patent/JP2006504511A/ja not_active Ceased
- 2003-07-14 EP EP03738346A patent/EP1524964B1/fr not_active Expired - Lifetime
- 2003-07-14 CA CA2492709A patent/CA2492709C/fr not_active Expired - Fee Related
- 2003-07-14 KR KR1020057000841A patent/KR101061309B1/ko not_active IP Right Cessation
- 2003-07-14 NZ NZ537654A patent/NZ537654A/en not_active IP Right Cessation
- 2003-07-14 AT AT03738346T patent/ATE489939T1/de not_active IP Right Cessation
- 2003-07-14 DE DE60335189T patent/DE60335189D1/de not_active Expired - Lifetime
- 2003-07-14 BR BR0312631-5A patent/BR0312631A/pt not_active IP Right Cessation
- 2003-07-14 CN CN03817081A patent/CN100594885C/zh not_active Expired - Fee Related
-
2004
- 2004-12-22 ZA ZA200410343A patent/ZA200410343B/en unknown
- 2004-12-22 IL IL16593004A patent/IL165930A0/xx unknown
-
2005
- 2005-02-17 NO NO20050860A patent/NO20050860L/no not_active Application Discontinuation
- 2005-08-25 HK HK05107482.5A patent/HK1075199A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60335189D1 (de) | 2011-01-13 |
CN100594885C (zh) | 2010-03-24 |
EP1524964B1 (fr) | 2010-12-01 |
US7780989B2 (en) | 2010-08-24 |
CN1668280A (zh) | 2005-09-14 |
KR101061309B1 (ko) | 2011-08-31 |
JP2006504511A (ja) | 2006-02-09 |
NO20050860L (no) | 2005-04-18 |
ES2355137T3 (es) | 2011-03-23 |
CA2492709A1 (fr) | 2004-01-29 |
BR0312631A (pt) | 2005-04-19 |
US20050202092A1 (en) | 2005-09-15 |
ATE489939T1 (de) | 2010-12-15 |
CA2492709C (fr) | 2012-01-24 |
IL165930A0 (en) | 2006-01-15 |
KR20050023432A (ko) | 2005-03-09 |
GB0216700D0 (en) | 2002-08-28 |
WO2004009057A1 (fr) | 2004-01-29 |
EP1524964A1 (fr) | 2005-04-27 |
ZA200410343B (en) | 2005-10-17 |
NZ537654A (en) | 2006-08-31 |
MXPA05000595A (es) | 2005-04-19 |
AU2003244871A1 (en) | 2004-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1075199A1 (en) | Process for the preparation of crystalline nano-particle dispersions | |
Raychoudhury et al. | Straining of polyelectrolyte-stabilized nanoscale zero valent iron particles during transport through granular porous media | |
Scharff et al. | Structure of C60 fullerene in water: spectroscopic data | |
Korbekandi et al. | Optimization of biological synthesis of silver nanoparticles using Lactobacillus casei subsp. casei | |
Das et al. | Microbial synthesis of multishaped gold nanostructures | |
Hirai et al. | Preparation of stable dispersions of colloidal gold in hexanes by phase transfer | |
CN104759635B (zh) | 一种负载型纳米零价铁复合材料的制备方法 | |
DE60220923D1 (de) | Wässrige dispersion stabiler nanopartikel eines wasserunlöslichen wirkstoffs und ein hilfsstoff wie mittelkettige triglyceride (mct) | |
Kong et al. | Facile synthesis of nickel nanowires with controllable morphology | |
CN109950014A (zh) | 一种弱水解体系制备磁性介孔二氧化硅复合微球的方法 | |
CN106430162A (zh) | 石墨烯水凝胶的制备方法 | |
Choi et al. | γ-ray synthesis and size characterization of CdS quantum dot (QD) particles using flow and sedimentation field-flow fractionation (FFF) | |
WO2008038134A1 (fr) | procÉdÉ de fabrication de nanoparticules de chitosane | |
CN108126199B (zh) | 一种可降解双响应智能高分子/硫化钼药物载体的制备方法 | |
CN101953817A (zh) | 一种载油溶性物质的微胶囊及其制备方法 | |
Razack et al. | A way to create a sustainable environment: Green nanotechnology–with an emphasis on noble metals | |
CN102416180B (zh) | 一种功能集成药物载体及其制备方法 | |
CN102990081B (zh) | 单分散、尺寸均一的贵金属纳米球的制备方法 | |
CN101457034B (zh) | 一种制备高分散性纳米固态粉体的方法 | |
CN106270498B (zh) | 一种对贵金属纳米粒子进行相转移的方法 | |
CN109970070B (zh) | 一种二氧化硅纳米管及其制备方法 | |
CN104001933B (zh) | 利用棉铃虫核型多角体蛋白提取物制备金纳米线的方法 | |
CN103451175B (zh) | 一种纳米磁性Fe3O4固定脂肪氧合酶及其制备方法和应用 | |
CN102557210B (zh) | 一种利用纳米碳管高效去除水体中藻类的方法 | |
CN110615431B (zh) | 一种具有稳定溶液分散性的二维纳米磁子制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20150714 |